Defilade Capital Management »

Medtronic shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Medtronic (MDT) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Medtronic

Tip: Access up to 7 years of quarterly data

All positions including Medtronic held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medtronic by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 303k 78.23

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Medtronic

BlackRock
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of America Corporation
Morgan Stanley
Massachusetts Financial Services
Deutsche Bank Aktiengesellschaft
Invesco
Franklin Resources
Norges Bank Investment Management
Capital World Investors
Royal Bank of Canada

View all funds holding Medtronic